Health'Monoclonal Antibody Treatment' Helps Reduce Severe Risks of COVID-19, But Why is the FDA Reserving it to Specific People? The Monoclonal Antibody Treatment speaks of a high recovery rate for COVID-19, but the FDA is holding it up for specific reasons.by Isaiah Richard
HealthControversial Aduhelm Alzheimer Drug's Quick Approval To Be Reviewed: US HHS Now Questions FDA's Decisionby Griffin Davis
HealthTikTok's Latest Trend Called 'Frozen Honey' Challenge Can Give You Diarrhea, Experts Warnby Sophie Webster
HealthFacebook Blocks COVID-19 Misinformation Researchers from NYU, Cuts off Access to Ad Libraryby Isabella James
Health#Techtimeslifehack: Reasons Why Unvaccinated People Should Get COVID-19 Vaccinesby Griffin Davis
HealthCOVID-19: University of Pittsburgh Researchers Develop Single-Domain Antibody For SARS-COV-2 Variantsby Joseph Henry
HealthThis U.S. State Has the Worst COVID-19 Hospitalization Rate Among Kids, Teens — Can You Guess Where?by Isabella James
TechSmartwatches Circadian Rhythm: Researchers Look for New Ways to Track Physiological Processes in Bodyby Isaiah Richard
HealthUNC Students 'Knew How to Buy Fake Vaccine Cards' to Comply with University Shot Requirementby Urian B.